We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ThromboGenics Signs Global and Exclusive in-Licensing Agreement with Galapagos

News   Mar 18, 2016

 
ThromboGenics Signs Global and Exclusive in-Licensing Agreement with Galapagos
 
 
 

RELATED ARTICLES

Blood Circulation Disorder Could Be an Autoimmune Disease

News

In a patient-based study, researchers have found evidence to suggest postural orthostatic tachycardia syndrome (POTS) could be an autoimmune disease.

READ MORE

First-of-Its-Kind Study Shows CAR-T Cell Therapy May Be Viable for Heart Disease Treatment

News

In a world first, researchers from Penn Medicine have used genetically modified T cells to target and ablate fibroblasts that contribute to the development of heart disease.

READ MORE

New Method Could Provide Better Food and Faster Analysis of Blood Tests

News

Researchers have discovered how to use deep learning to speed up the analysis of gas chromatographic data. The new method will have a major impact on quality, efficiency and cost when examining various data – from blood tests, to oil pollution testing to the fermentation of cheese.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE